Do Young Lim

2.6k total citations
44 papers, 1.9k citations indexed

About

Do Young Lim is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Do Young Lim has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Do Young Lim's work include Cancer-related Molecular Pathways (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Pharmacological Effects of Natural Compounds (4 papers). Do Young Lim is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Pharmacological Effects of Natural Compounds (4 papers). Do Young Lim collaborates with scholars based in United States, South Korea and China. Do Young Lim's co-authors include Jung Han Yoon Park, Zigang Dong, Ann M. Bode, Angela L. Tyner, Jung H.Y. Park, Hanyong Chen, Ki Won Lee, Jae In Jung, Han‐Jin Cho and Hyun Ju Choi and has published in prestigious journals such as Science, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Do Young Lim

42 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Do Young Lim United States 25 1.0k 334 287 231 214 44 1.9k
Anfernee Kai‐Wing Tse Hong Kong 28 980 0.9× 309 0.9× 218 0.8× 208 0.9× 297 1.4× 58 2.0k
Numsen Hail United States 29 1.6k 1.6× 385 1.2× 275 1.0× 163 0.7× 326 1.5× 41 2.4k
Gopalakrishnan Ramakrishnan United States 29 1.5k 1.5× 440 1.3× 251 0.9× 187 0.8× 385 1.8× 64 2.9k
Yumiko Yasui Japan 30 1.1k 1.0× 283 0.8× 211 0.7× 239 1.0× 327 1.5× 74 2.5k
Javadi Monisha India 21 1.1k 1.1× 206 0.6× 171 0.6× 307 1.3× 278 1.3× 29 2.2k
Heyao Wang China 30 1.2k 1.1× 164 0.5× 197 0.7× 327 1.4× 163 0.8× 111 2.4k
Anjana Bhardwaj United States 17 1.4k 1.3× 377 1.1× 273 1.0× 186 0.8× 440 2.1× 37 2.6k
In‐Hye Ham South Korea 28 918 0.9× 406 1.2× 221 0.8× 124 0.5× 425 2.0× 83 1.9k
Jeong‐Hyeon Ko South Korea 22 1.1k 1.1× 475 1.4× 145 0.5× 167 0.7× 352 1.6× 38 2.1k
Benny K.H. Tan Singapore 12 1.2k 1.2× 483 1.4× 261 0.9× 147 0.6× 260 1.2× 16 2.2k

Countries citing papers authored by Do Young Lim

Since Specialization
Citations

This map shows the geographic impact of Do Young Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Do Young Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Do Young Lim more than expected).

Fields of papers citing papers by Do Young Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Do Young Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Do Young Lim. The network helps show where Do Young Lim may publish in the future.

Co-authorship network of co-authors of Do Young Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Do Young Lim. A scholar is included among the top collaborators of Do Young Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Do Young Lim. Do Young Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sturmlechner, Ines, Cheng Zhang, Karthik B. Jeganathan, et al.. (2021). p21 produces a bioactive secretome that places stressed cells under immunosurveillance. Science. 374(6567). eabb3420–eabb3420. 177 indexed citations
2.
Wang, Qiushi, Tianshun Zhang, Do Young Lim, et al.. (2020). ARC Is a Critical Protector against Inflammatory Bowel Disease (IBD) and IBD-Associated Colorectal Tumorigenesis. Cancer Research. 80(19). 4158–4171. 5 indexed citations
3.
Zykova, Tatyana A., Feng Zhu, Lei Wang, et al.. (2018). Targeting PRPK Function Blocks Colon Cancer Metastasis. Molecular Cancer Therapeutics. 17(5). 1101–1113. 15 indexed citations
4.
5.
Jeon, Young Jin, Joohyun Ryu, Do Young Lim, et al.. (2017). The CUG-translated WT1, not AUG-WT1, is an oncogene. Carcinogenesis. 38(12). 1228–1240. 14 indexed citations
6.
Lim, Do Young, Gyoo Taik Kwon, Ji Hee Kim, et al.. (2016). Benzyl Isothiocyanate Inhibits Prostate Cancer Development in the Transgenic Adenocarcinoma Mouse Prostate (TRAMP) Model, Which Is Associated with the Induction of Cell Cycle G1 Arrest. International Journal of Molecular Sciences. 17(2). 264–264. 24 indexed citations
7.
Lim, Do Young, Mee‐Hyun Lee, Seung Ho Shin, et al.. (2014). (+)-2-(1-Hydroxyl-4-Oxocyclohexyl) Ethyl Caffeate Suppresses Solar UV-Induced Skin Carcinogenesis by Targeting PI3K, ERK1/2, and p38. Cancer Prevention Research. 7(8). 856–865. 7 indexed citations
8.
Lim, Tae‐Gyu, Sungyoung Lee, Zunnan Huang, et al.. (2014). Curcumin Suppresses Proliferation of Colon Cancer Cells by Targeting CDK2. Cancer Prevention Research. 7(4). 466–474. 91 indexed citations
9.
Yang, Ge, Yang Fu, Margarita Malakhova, et al.. (2014). Caffeic Acid Directly Targets ERK1/2 to Attenuate Solar UV-Induced Skin Carcinogenesis. Cancer Prevention Research. 7(10). 1056–1066. 47 indexed citations
10.
Kang, Seong A., Michael E. Pacold, Christopher Cervantes, et al.. (2013). mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin. Science. 341(6144). 1236566–1236566. 3 indexed citations
11.
Kim, Mi-Sung, Jong‐Eun Kim, Do Young Lim, et al.. (2013). Naproxen Induces Cell-Cycle Arrest and Apoptosis in Human Urinary Bladder Cancer Cell Lines and Chemically Induced Cancers by Targeting PI3K. Cancer Prevention Research. 7(2). 236–245. 69 indexed citations
12.
Kim, Dong Joon, Mee‐Hyun Lee, Kanamata Reddy, et al.. (2013). CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo. Carcinogenesis. 34(5). 1134–1143. 5 indexed citations
13.
Yao, Ke, Hanyong Chen, Yong‐Yeon Cho, et al.. (2013). JNK1 and 2 play a negative role in reprogramming to pluripotent stem cells by suppressing Klf4 activity. Stem Cell Research. 12(1). 139–152. 24 indexed citations
14.
Xie, Hua, Mee‐Hyun Lee, Feng Zhu, et al.. (2012). Identification of an Aurora Kinase Inhibitor Specific for the Aurora B Isoform. Cancer Research. 73(2). 716–724. 26 indexed citations
15.
16.
Xie, Hua, Feng Zhu, Zunnan Huang, et al.. (2012). Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo. Carcinogenesis. 33(9). 1814–1821. 14 indexed citations
17.
Lim, Do Young, et al.. (2009). Induction of Cell Cycle Arrest in Prostate Cancer Cells by the Dietary Compound Isoliquiritigenin. Journal of Medicinal Food. 12(1). 8–14. 48 indexed citations
18.
Lim, Do Young & Jung Han Yoon Park. (2009). Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(5). G1060–G1068. 81 indexed citations
19.
Lim, Do Young, Angela L. Tyner, Jae‐Bong Park, et al.. (2005). Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. Journal of Cellular Physiology. 205(1). 107–113. 50 indexed citations
20.
Lu, Xianghua, Jae In Jung, Han‐Jin Cho, et al.. (2005). Fisetin Inhibits the Activities of Cyclin-Dependent Kinases Leading to Cell Cycle Arrest in HT-29 Human Colon Cancer Cells. Journal of Nutrition. 135(12). 2884–2890. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anfernee Kai‐Wing Tse Breakdown of academic impact, for papers by Numsen Hail Breakdown of academic impact, for papers by Gopalakrishnan Ramakrishnan Breakdown of academic impact, for papers by Yumiko Yasui Breakdown of academic impact, for papers by Javadi Monisha Breakdown of academic impact, for papers by Heyao Wang Breakdown of academic impact, for papers by Anjana Bhardwaj Breakdown of academic impact, for papers by In‐Hye Ham Breakdown of academic impact, for papers by Jeong‐Hyeon Ko Breakdown of academic impact, for papers by Benny K.H. Tan
Rankless by CCL
2026